We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Urinary Retention Global Clinical Trials Review, H2, 2018

Published: September 2018
Pages: 76
Code: 9C68E1BECE507189A309887543897A98
Format: PDF
Publisher GlobalData
From Add to basket
$ 2,500.00
GlobalData's clinical trial report, “ provides an overview of Urinary Retention clinical trials scenario. This report provides top line data relating to the clinical trials on Urinary Retention. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Additonal Information

  • - The report provides a snapshot of the global clinical trials landscape
  • - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • - The Report provides enrollment trends for the past five years
  • - Report provides latest news for the past three months
  • *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Sanofi
GlaxoSmithKline Plc
Dignify Therapeutics LLC
Cook Medical Inc
China Resources Pharmaceutical Group Ltd
C. H. Boehringer Sohn AG & Co KG
Blumont Pharma Ltd
Apotex Inc
Anapharm Inc.
Allergan Plc

Reasons to buy

Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Add to basket
  • Table of Contents
  • Table of Contents 2
  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Clinical Trials by G7 Countries: Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 27
  • Subjects Recruited Over a Period of Time 28
  • Clinical Trials by Sponsor Type 29
  • Prominent Sponsors 30
  • Top Companies Participating in Urinary Retention Therapeutics Clinical Trials 32
  • Prominent Drugs 34
  • Clinical Trial Profile Snapshots 35
  • Appendix 74
  • Abbreviations 74
  • Definitions 74
  • Research Methodology 75
  • Secondary Research 75
  • About GlobalData 75
  • Contact Us 76
  • Source 76
  • List of Tables
  • Urinary Retention Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Urinary Retention Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Urinary Retention Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Urinary Retention Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Urinary Retention Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Urinary Retention Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Urinary Retention Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
  • Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2018* 16
  • Urinary Retention Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Urinary Retention Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2018* 20
  • Urinary Retention Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
  • Urinary Retention Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
  • Urinary Retention Therapeutics, Global, Clinical Trials by Phase, 2018* 23
  • Urinary Retention Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
  • Urinary Retention Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
  • Urinary Retention Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
  • Urinary Retention Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
  • Urinary Retention Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
  • Urinary Retention Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
  • Urinary Retention Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
  • Urinary Retention Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
  • List of Figures
  • Urinary Retention Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Urinary Retention Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Urinary Retention Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Urinary Retention Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Urinary Retention Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Urinary Retention Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
  • Urinary Retention Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
  • Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2018* 15
  • Urinary Retention Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Urinary Retention Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2018* 19
  • Urinary Retention Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
  • Urinary Retention Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
  • Urinary Retention Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
  • Urinary Retention Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
  • Urinary Retention Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
  • Urinary Retention Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
  • Urinary Retention Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
  • Urinary Retention Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
  • Urinary Retention Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
  • Urinary Retention Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
  • Urinary Retention Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
  • GlobalData Methodology 75

Keywords
;